Researchers recruit football, hockey players to better understand brains of living athletes

Researchers from Mount Sinai’s Icahn School of Medicine are using cutting-edge ligands to examine the brains of NFL and NHL players who are at-risk for brain damage, the New York Daily News reports. 

The newspaper said the results are preliminary, but the researchers are recruiting hockey players to examine their brains using PET scans. They hope to better understand chronic traumatic encephalopathy, an illness found posthumously in a number of athletes.

Read more at the link below:

Tim Casey,

Executive Editor

Tim Casey joined TriMed Media Group in 2015 as Executive Editor. For the previous four years, he worked as an editor and writer for HMP Communications, primarily focused on covering managed care issues and reporting from medical and health care conferences. He was also a staff reporter at the Sacramento Bee for more than four years covering professional, college and high school sports. He earned his undergraduate degree in psychology from the University of Notre Dame and his MBA degree from Georgetown University.

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.